Search

Ralph R Weichselbaum

from Chicago, IL
Age ~78

Ralph Weichselbaum Phones & Addresses

  • 1909 Burling St, Chicago, IL 60614 (312) 951-0671 (312) 951-0675
  • 1913 N Burling St, Chicago, IL 60614 (773) 951-0675
  • Delray Beach, FL
  • Michigan City, IN
  • Onset, MA
  • 1913 N Burling St, Chicago, IL 60614 (773) 301-5046

Work

Company: Univ Chicago Radiation Oncology Address: 5758 S Maryland Ave Suite 1D, Chicago, IL 60637 Phones: (773) 702-6870

Education

School / High School: University of Illinois At Chicago / College of Medicine 1971

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Therapeutic Radiology

Emails

Specialities

Radiology • Therapeutic Radiology

Professional Records

Medicine Doctors

Ralph Weichselbaum Photo 1

Dr. Ralph R Weichselbaum, Chicago IL - MD (Doctor of Medicine)

View page
Specialties:
Radiology
Therapeutic Radiology
Address:
Univ Chicago Radiation Oncology
5758 S Maryland Ave Suite 1D, Chicago, IL 60637
(773) 702-6870 (Phone)
Certifications:
Therapeutic Radiology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univ Chicago Radiation Oncology
5758 S Maryland Ave Suite 1D, Chicago, IL 60637

Sherman Hospital
1425 North Randall Road, Elgin, IL 60123

University of Illinois Hospital & Health Science System
1740 West Taylor Street, Chicago, IL 60612
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1971
Medical School
Alameda County Medical Center-Highland Campus
Graduated: 1971
Medical School
Harvard Medical School
Graduated: 1971
Medical School
Jt Ctr Rad Therapy
Graduated: 1971
Medical School
Harvard Sch Ph
Graduated: 1971
Ralph Weichselbaum Photo 2

Ralph R. Weichselbaum

View page
Specialties:
Radiation Oncology
Work:
University Of Chicago Radiation Oncology
5758 S Maryland Ave STE 1D, Chicago, IL 60637
(773) 702-6870 (phone), (773) 834-7183 (fax)
Education:
Medical School
University of Illinois, Chicago College of Medicine
Graduated: 1971
Languages:
English
Description:
Dr. Weichselbaum graduated from the University of Illinois, Chicago College of Medicine in 1971. He works in Chicago, IL and specializes in Radiation Oncology. Dr. Weichselbaum is affiliated with Advocate Sherman Hospital and University Of Chicago Medicine.
Ralph Weichselbaum Photo 3

Ralph R Weichselbaum, Chicago IL

View page
Specialties:
Radiology
Therapeutic Radiology
Radiation Oncology
Medical Oncology
Work:
University of Chicago
5758 S Maryland Ave, Chicago, IL 60637
The University of Chicago Medicine
5841 S Maryland Ave, Chicago, IL 60637
UIC Dept of Radiation Oncology
1801 W Taylor St, Chicago, IL 60612
Education:
University of Illinois at Chicago (1971)

Resumes

Resumes

Ralph Weichselbaum Photo 4

Professor At University Of Chicago Hospitals

View page
Position:
professor at University of Chicago Hospitals
Location:
Greater Chicago Area
Industry:
Hospital & Health Care
Work:
University of Chicago Hospitals
professor
Ralph Weichselbaum Photo 5

D. K. Ludwig Professor And Chairman At The University Of Chicago Medical Center

View page
Position:
D. K. Ludwig Professor and Chairman at The University of Chicago Medical Center
Location:
Greater Chicago Area
Industry:
Hospital & Health Care
Work:
The University of Chicago Medical Center
D. K. Ludwig Professor and Chairman

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ralph Weichselbaum
Doctor Of Medicine
University of Chicago Comer Childrens Hospital
Offices and Clinics of Doctors of Medicine
5721 S Maryland Ave, Chicago, IL 60637
Ralph Weichselbaum
Doctor Of Medicine
University of Chicago Comer Childrens Hospital
Offices and Clinics of Medical Doctors
5721 S Maryland Ave, Chicago, IL 60637
(773) 702-6150
Ralph Robert Weichselbaum
Ralph Weichselbaum MD
Oncology · Radiology
5841 S Maryland Ave, Chicago, IL 60637
(773) 702-9200
Ralph R. Weichselbaum
Oncology
University of Chicago Hospital Blood Bank Donor Appointments
General Hospital
5758 S Maryland Ave, Chicago, IL 60637
Ralph Weichselbaum
Doctor Of Medicine
University of Chicago Comer Childrens Hospital
Offices and Clinics of Doctors of Medicine
5721 S Maryland Ave, Chicago, IL 60637

Publications

Isbn (Books And Publications)

Cancer Medicine

View page
Author

Ralph R. Weichselbaum

ISBN #

0683040952

Us Patents

Combination Of Radiotherapy And Anti-Angiogenic Factors

View page
US Patent:
6420335, Jul 16, 2002
Filed:
Jun 16, 1999
Appl. No.:
09/334084
Inventors:
Ralph R. Weichselbaum - Chicago IL
Vikas P. Sukhatme - Newton MA
Donald W. Kufe - Wellesley MA
Assignee:
Dana Farber Cancer Institute, Inc. - Boston MA
ARCH Development Corporation - Chicago IL
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
A01N 3718
US Classification:
514 2, 530350, 378 65, 514 1, 600 1
Abstract:
The present invention relates generally to the fields of angiogenesis and cancer therapy. More particularly, it concerns the use of anti-angiogenic factors in cancer therapy. The present invention demonstrates that angiostatin or endostatin can sensitize a cell to radiation therapy. Methods and compositions for inhibiting growth, sensitizing a cell to radiotherapy and treating cancer growth by first inhibiting angiogenesis and then employing radiotherapy are described.

Chelerythrine-Based Therapies For Cancer

View page
US Patent:
6426351, Jul 30, 2002
Filed:
Aug 11, 2000
Appl. No.:
09/637816
Inventors:
Ralph R. Weichselbaum - Chicago IL
Donald W. Kufe - Wellesley MA
Steven J. Chmura - Chicago IL
Mary E. Dolan - Oak Park IL
Assignee:
Dana-Farber Cancer, Inc. - Boston MA
Arch Development Corporation - Chicago IL
International Classification:
A61K 3144
US Classification:
514280
Abstract:
Chelerythrine is an effective inhibitor of solid tumor growth and is extremely cytotoxic in combination with chemotherapeutic agents that directly damage DNA.

Phospholipase A2 Inhibitors As Mediators Of Gene Expression

View page
US Patent:
6486170, Nov 26, 2002
Filed:
May 24, 1994
Appl. No.:
08/248058
Inventors:
Dennis E. Hallahan - Des Plaines IL
Ralph R. Weichselbaum - Chicago IL
Donald W. Kufe - Wellesley MA
Assignee:
Arch Development Corporation - Chicago IL
International Classification:
A61K 3144
US Classification:
514297, 4352402, 4351731, 514747, 514263, 514291, 514169
Abstract:
A signaling pathway is identified that involves the activation of phospholipase A2 and protein kinase C in human cells, which in turn confers x-ray induction of the tumor necrosis factor (TNF) gene. Inhibition of phospholipase A2 abolishes radiation-mediated arachidonate production, as well as the subsequent activation of protein kinase C and TNF gene expression. These phospholipase A2 inhibitors may be used to ameliorate the adverse-effects of radiotherapy associated with TNF production.

Dna Damaging Agents In Combination With Tyrosine Kinase Inhibitors

View page
US Patent:
6524832, Feb 25, 2003
Filed:
Aug 19, 1994
Appl. No.:
08/309315
Inventors:
Donald Kufe - Wellesley MA
Ralph R. Weichselbaum - Chicago IL
Assignee:
Arch Development Corporation - Chicago IL
International Classification:
C12N 1300
US Classification:
4351731, 4351734, 435212, 424 945, 514 25, 514 27, 514456, 514457, 600 1
Abstract:
The present invention relates to the signalling pathways connecting DNA damage, such as that induced by ionizing radiation or alkylating agents, and phosphorylation by tyrosine kinases.

Tumor Radiosensitization And/Or Chemopotentiation Using Isocoumarin Derivatives

View page
US Patent:
6589981, Jul 8, 2003
Filed:
Feb 27, 2001
Appl. No.:
09/794417
Inventors:
Corinne L. Reimer - Sommersville MA
Naoki Agata - Fujisawa, JP
Tomio Takeuchi - Tokyo, JP
Hiroyuki Kumagai - Chigasaki, JP
Takeo Yoshioka - Ayase, JP
Masaaki Ishizuka - Mishima, JP
Donald W. Kufe - Wellesley MA
Ralph R. Weichselbaum - Chicago IL
Assignee:
ILEX Oncology, Inc. - San Antonio TX
Mercian Corporation - Tokyo
International Classification:
A61K 3135
US Classification:
514456
Abstract:
A method for enhancing the efficacy of chemotherapy and/or radiation in the treatment of cancer in animals, particularly humans, is provided wherein certain isocoumarin derivatives which exhibit unique radiosensitization activity and/or chemopotentiation properties are employed in a combination treatment with ionizing radiation and/or chemotherapy.

Gene Transcription And Ionizing Radiation: Methods And Compositions

View page
US Patent:
6605712, Aug 12, 2003
Filed:
Sep 11, 1992
Appl. No.:
07/943812
Inventors:
Ralph R. Weichselbaum - Chicago IL
Dennis E. Hallahan - Chicago IL
Vikas P. Sukhatme - Chicago IL
Donald W. Kufe - Wellesley MA
Assignee:
Arch Development Corporation - Chicago IL
International Classification:
C12N 1511
US Classification:
536 241, 424 9321, 4353201, 514 44
Abstract:
The present invention provides a DNA molecule comprising a radiation responsive enhancer-promoter operatively linked to an encoding region that encodes at least one polypeptide. An encoding region can comprise a single encoding sequence for a polypeptide or two or more encoding sequences encoding DNA binding, activation or repression domains of a transcription factor. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.

Genetically Engineered Herpes Virus For The Treatment Of Cardiovascular Disease

View page
US Patent:
6846670, Jan 25, 2005
Filed:
Nov 28, 2001
Appl. No.:
09/995475
Inventors:
Lewis B. Schwartz - Hinsdale IL, US
Ralph R. Weichselbaum - Chicago IL, US
Bernard Roizman - Chicago IL, US
Assignee:
The University of Chicago - Chicago IL
International Classification:
C12N 1500
US Classification:
4353201, 435 691, 4352351, 4242291, 4241991
Abstract:
The present invention provides methods of expressing a nucleic acid or producing a proteinaceous composition encoded by a nucleic acid in vascular and cardiovascular cells by administration of a herpesvirus vector. The present invention provides methods of producing a therapeutic benefit in vascular and cardiovascular tissue by administration of a herpesvirus vector. In additional aspects, the invention concerns combination therapies for vascular and cardiovascular diseases comprising administration of a herpesvirus vector and treatment with at least one addition pharmacological agent or surgical procedure.

Gene Transcription And Ionizing Radiation: Methods And Compositions

View page
US Patent:
7041653, May 9, 2006
Filed:
Dec 5, 2000
Appl. No.:
09/730630
Inventors:
Ralph R. Weichselbaum - Chicago IL, US
Dennis E. Hallahan - Chicago IL, US
Vikas P. Sukhatme - Chicago IL, US
Donald W. Kufe - Wellesley MA, US
Assignee:
The University of Chicago - Chicago IL
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A01N 43/04
A01N 63/00
C07H 21/02
C07H 21/04
C12N 15/63
US Classification:
514 44, 536 231, 536 235, 536 241, 424 931, 424 932, 435455
Abstract:
The present invention provides a DNA molecule comprising a radiation responsive enhancer-promoter operatively linked to an encoding region that encodes at least one polypeptide. An encoding region can comprise a single encoding sequence for a polypeptide or two or more encoding sequences encoding DNA binding, activation or repression domains of a transcription factor. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.
Ralph R Weichselbaum from Chicago, IL, age ~78 Get Report